A Platform for High-Resolution Immune Liquid Biopsy Analysis to Predict Response in Patients with Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Preliminary Data from I-RENE Trial (Meet-Uro 8 Study).
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Biomarkers for Immunotherapy,Renal Cell Carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined